Differentiation of glioblastoma multiforme from metastatic brain tumor using proton magnetic resonance spectroscopy, diffusion and perfusion metrics at 3 T

Cancer Imaging

Volumn 12, Issue 3, 2012, Pages 423-436

  Tsougos, Ioannis ^a   Svolos, Patricia ^a   Kousi, Evanthia ^a   Fountas, Konstantinos ^b   Theodorou, Kyriaki ^a   Fezoulidis, Ioannis ^b   Kapsalaki, Eftychia ^b  

^a UNIVERSITY OF THESSALY   (Greece)

^b UNIVERSITY HOSPITAL OF LARISSA   (Greece)

Author keywords

Diffusion weighted imaging; Dynamic susceptibility contrast enhanced imaging; Glioblastoma; Metastasis; Spectroscopy

Indexed keywords

CHOLINE; CONTRAST MEDIUM; CREATINE; N ACETYLASPARTIC ACID;

ADULT; AGED; ARTICLE; BRAIN BLOOD FLOW; BRAIN METASTASIS; BRAIN TUMOR; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; DYNAMIC SUSCEPTIBILITY CONTRAST ENHANCED IMAGING; FEMALE; FRACTIONAL ANISOTROPY; GLIOBLASTOMA; HUMAN; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTON NUCLEAR MAGNETIC RESONANCE;

ADULT; AGED; ASPARTIC ACID; BRAIN; BRAIN CHEMISTRY; BRAIN NEOPLASMS; CHOLINE; CREATINE; DIAGNOSIS, DIFFERENTIAL; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; GLIOBLASTOMA; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PROSPECTIVE STUDIES; ROC CURVE;

EID: 84870458886     PISSN: None     EISSN: 14707330     Source Type: Journal    
DOI: 10.1102/1470-7330.2012.0038     Document Type: Article

References (58)

1. Chiang IC, Kuo YT, Lu CY, et al. Distinction between high-grade gliomas and solitary metastases using peritumoral 3-T magnetic resonance spectroscopy, diffusion, and perfusion imagings. Neuroradiology 2004; 46: 619-627. PMid:15243726.
2. Hollingworth W, Medina LS, Lenkinski RE, et al. A systematic literature review of magnetic resonance spectroscopy for the characterization of brain tumors. AJNR Am J Neuroradiol 2006; 27: 1404-1411. PMid:16908548.
3. Cha S, Pierce S, Knopp EA, et al. Dynamic contrast-enhanced T2*-weighted MR imaging of tumefactive demyelinating lesions. AJNR Am J Neuroradiol 2001; 22: 1109-1116. PMid:11415906.
4. Warren KE. NMR spectroscopy and pediatric brain tumors. Oncologist 2004; 9: 312-318. doi:10.1634/theoncologist.9-3-312. PMid:15169986.
5. Cha S. Neuroimaging in neuro-oncology. Neurotherapeutics 2009; 6: 465-477. doi:10.1016/j.nurt.2009.05.002. PMid:19560737.
6. Toh CH, Castillo M, Wong AM, et al. Primary cerebral lymphoma and glioblastoma multiforme: differences in diffusion characteristics evaluated with diffusion tensor imaging. AJNR Am J Neuroradiol 2008; 29: 471-475. doi:10.3174/ajnr.A0872. PMid:18065516.
7. Barker PB, Hearshen DO, Boska MD. Single-voxel proton MRS of the human brain at 1.5T and 3.0T. Magn Reson Med 2001; 45: 765-769. doi:10.1002/mrm.1104. PMid:11323802.
8. Law M, Cha S, Knopp EA, et al. High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging. Radiology 2002; 222: 715-721. doi:10.1148/radiol.2223010558. PMid:11867790.
9. 1H magnetic resonance spectroscopy. Magn Reson Med 2003; 49: 223-232. doi:10.1002/mrm.10367. PMid:12541241.
10. Moller-Hartmann W, Herminghaus S, Krings T, et al. Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions. Neuroradiology 2002; 44: 371-381. PMid:12012120.
11. Fan G, Sun B, Wu Z, et al. In vivo single-voxel proton MR spectroscopy in the differentiation of high-grade gliomas and solitary metastases. Clin Radiol 2004; 59: 77-85. doi:10.1016/j.crad.2003.08.006. PMid:14697379.
12. Bulakbasi N, Kocaoglu M, Ors F, et al. Combination of single-voxel proton MR spectroscopy and apparent diffusion coefficient calculation in the evaluation of common brain tumors. AJNR Am J Neuroradiol 2003; 24: 225-233. PMid:12591638.
13. Chenevert TL, Brunberg JA, Pipe JG. Anisotropic diffusion in human white matter: demonstration with MR techniques in vivo. Radiology 1990; 177: 401-405. PMid:2217776.
14. Doran M, Hajnal JV, Van Bruggen N, et al. Normal and abnormal white matter tracts shown by MR imaging using directional diffusion weighted sequences. J Comput Assist Tomogr 1990; 14: 865-873. doi:10.1097/00004728- 199011000-00001. PMid:2229559.
15. Hansen JR. Pulsed NMR study of water mobility in muscle and brain tissue. Biochim Biophys Acta 1971; 230: 482-486. doi:10.1016/0304-4165(71)90177-2. PMid:5581279.
16. Liu X, Tian W, Kolar B, et al. MR diffusion tensor and perfusion-weighted imaging in preoperative grading of supratentorial nonenhancing gliomas. Neuro-Oncology 2011; 13: 447-455. doi:10.1093/neuonc/noq197. PMid:21297125.
17. Chawla S, Zhang Y, Wang S, et al. Proton magnetic resonance spectroscopy in differentiating glioblastomas from primary cerebral lymphomas and brain metastases. J Comput Assist Tomogr 2010; 34: 836-841. doi:10.1097/RCT. 0b013e3181ec554e. PMid:21084897.
18. Lu S, Ahn D, Johnson G, et al. Peritumoral diffusion tensor imaging of high-grade gliomas and metastatic brain tumors. AJNR Am J Neuroradiol 2003; 24: 937-941. PMid:12748097.
19. Morita K, Matsuzawa H, Fujii Y, et al. Diffusion tensor analysis of peritumoral edema using lambda chart analysis indicative of the heterogeneity of the microstructure within edema. J Neurosurg 2005; 102: 336-341. PMid:15739563.
20. Oh J, Cha S, Aiken AH, et al. Quantitative apparent diffusion coefficients and T2 relaxation times in characterizing contrast enhancing brain tumors and regions of peritumoral edema. J Magn Reson Imaging 2005; 21: 701-708. doi:10.1002/jmri.20335. PMid:15906339.
21. Pavlisa G, Rados M, Pavic L, et al. The differences of water diffusion between brain tissue infiltrated by tumor and peritumoral vasogenic edema. Clin Imaging 2009; 33: 96-101. doi:10.1016/j.clinimag.2008.06.035. PMid:19237051.
22. Lee EJ, ter Brugge K, Mikulis D, et al. Diagnostic value of peritumoral minimum apparent diffusion coefficient for differentiation of glioblastoma multiforme from solitary metastatic lesions. AJR Am J Roentgenol 2011; 196: 71-76. doi:10.2214/AJR.10.4752. PMid:21178049.
23. Yamasaki F, Kurisu K, Satoh K, et al. Apparent diffusion coefficient of human brain tumors at MR imaging. Radiology 2005; 235: 985-991. doi:10.1148/radiol.2353031338. PMid:15833979.
24. Reiche W, Schuchardt V, Hagen T, et al. Differential diagnosis of intracranial ring enhancing cystic mass lesions-role of diffusion-weighted imaging (DWI) and diffusion-tensor imaging (DTI). Clin Neurol Neurosurg 2010; 112: 218-225. doi:10.1016/j.clineuro.2009.11.016. PMid:20053496.
25. Lu S, Ahn D, Johnson G, et al. Diffusion-tensor MR imaging of intracranial neoplasia and associated peritumoral edema: introduction of the tumor infiltration index. Radiology 2004; 232: 221-228. doi:10.1148/radiol. 2321030653. PMid:15220505.
26. Krabbe K, Gideon P, Wagn P, et al. MR diffusion imaging of human intracranial tumours. Neuroradiology 1997; 39: 483-489. doi:10.1007/ s002340050450. PMid:9258924.
27. Bruhn H, Frahm J, Gyngell ML, et al. Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: initial experience in patients with cerebral tumors. Radiology 1989; 172: 541-548. PMid:2748837.
28. Server A, Josefsen R, Kulle B, et al. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors. Acta Radiol 2010; 51: 316-325. doi:10.3109/ 02841850903482901. PMid:20092374.
29. 1H-MR spectroscopy in peritumoral brain edema. AJNR Am J Neuroradiol 2007; 28: 1287-1291. doi:10.3174/ajnr.A0564. PMid:17698529.
30. 1H spectroscopy. J Magn Reson Imaging 2004; 20: 187-192. doi:10.1002/jmri.20093. PMid:15269942.
31. De Edelenyi FS, Rubin C, Esteve F, et al. A new approach for analyzing proton magnetic resonance spectroscopic images of brain tumors: nosologic images. Nat Med 2000; 6: 1287-1289. PMid:11062544.
32. Preul MC, Caramanos Z, Collins DL, et al. Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy. Nat Med 1996; 2: 323-325. doi:10.1038/nm0396-323. PMid:8612232.
33. Dowling C, Bollen AW, Noworolski SM, et al. Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens. AJNR Am J Neuroradiol 2001; 22: 604-612. PMid:11290466.
34. Weber MA, Zoubaa S, Schlieter M, et al. Diagnostic performance of spectroscopic and perfusion MRI for distinction of brain tumors. Neurology 2006; 66: 1899-1906. doi:10.1212/01.wnl.0000219767.49705.9c. PMid:16801657.
35. Chernov MF, Kubo O, Hayashi M, et al. Proton MRS of the peritumoral brain. J Neurol Sci 2005; 228: 137-142. doi:10.1016/j.jns.2004.11.039. PMid:15694194.
36. Sinha S, Bastin ME, Whittle IR, et al. Diffusion tensor MR imaging of high-grade cerebral gliomas. AJNR Am J Neuroradiol 2002; 23: 520-527. PMid:11950638.
37. Beppu T, Inoue T, Shibata Y, et al. Measurement of fractional anisotropy using diffusion tensor MRI in supratentorial astrocytic tumors. J Neurooncol 2003; 63: 109-116. doi:10.1023/A:1023977520909. PMid:12825815.
38. Kono K, Inoue Y, Nakayama K, et al. The role of diffusion-weighted imaging in patients with brain tumors. AJNR Am J Neuroradiol 2001; 22: 1081-1088. PMid:11415902.
39. Castillo M, Smith JK, Kwock L, et al. Apparent diffusion coefficients in the evaluation of high-grade cerebral gliomas. AJNR Am J Neuroradiol 2001; 22: 60-64. PMid:11158889.
40. Provenzale JM, McGraw P, Mhatre P, et al. Peritumoral brain regions in gliomas and meningiomas: investigation with isotropic diffusion-weighted MR imaging and diffusion-tensor MR imaging. Radiology 2004; 232: 451-460. doi:10.1148/radiol.2322030959. PMid:15215555.
41. Rees JH, Smirniotopoulos JG, Jones RV, et al. Glioblastoma multiforme: radiologic-pathologic correlation. Radiographics 1996; 16: 1413-1438; quiz 62-63. PMid:8946545.
42. Altman DA, Atkinson DS, Jr. Brat DJ. Best cases from the AFIP: glioblastoma multiforme. Radiographics 2007; 27: 883-888. doi:10.1148/rg. 273065138. PMid:17495298.
43. Kinoshita M, Hashimoto N, Goto T, et al. Fractional anisotropy and tumor cell density of the tumor core show positive correlation in diffusion tensor magnetic resonance imaging of malignant brain tumors. Neuroimage 2008; 43: 29-35. doi:10.1016/j.neuroimage.2008.06.041. PMid:18672074.
44. Beppu T, Inoue T, Shibata Y, et al. Fractional anisotropy value by diffusion tensor magnetic resonance imaging as a predictor of cell density and proliferation activity of glioblastomas. Surg Neurol 2005; 63: 56-61. doi:10.1016/j.surneu.2004.02.034. PMid:15639528.
45. Stadlbauer A, Ganslandt O, Buslei R, et al. Gliomas: histopathologic evaluation of changes in directionality and magnitude of water diffusion at diffusion-tensor MR imaging. Radiology 2006; 240: 803-810. doi:10.1148/radiol. 2403050937. PMid:16926329.
46. Wang S, Kim S, Chawla S, et al. Differentiation between glioblastomas and solitary brain metastases using diffusion tensor imaging. Neuroimage 2009; 44: 653-660. doi:10.1016/j.neuroimage.2008.09.027. PMid:18951985.
47. Blasel S, Jurcoane A, Franz K, et al. Elevated peritumoural rCBV values as a mean to differentiate metastases from high-grade gliomas. Acta Neurochir (Wien) 2010; 152: 1893-1899. doi:10.1007/s00701-010-0774-7.
48. Cha S. Perfusion MR imaging of brain tumors. Top Magn Reson Imaging 2004; 15: 279-289. doi:10.1097/00002142-200410000-00002. PMid:15627003.
49. Server A, Orheim TE, Graff BA, et al. Diagnostic examination performance by using microvascular leakage, cerebral blood volume, and blood flow derived from 3-T dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in the differentiation of glioblastoma multiforme and brain metastasis. Neuroradiology 2011; 53: 319-330. doi:10.1007/s00234-010-0740-3. PMid:20625709.
50. Hakyemez B, Erdogan C, Gokalp G, et al. Solitary metastases and high-grade gliomas: radiological differentiation by morphometric analysis and perfusion-weighted MRI. Clin Radiol 2010; 65: 15-20. doi:10.1016/j.crad.2009.09. 005. PMid:20103416.
51. Cho SK, Na DG, Ryoo JW, et al. Perfusion MR imaging: clinical utility for the differential diagnosis of various brain tumors. Korean J Radiol 2002; 3: 171-179. doi:10.3348/kjr.2002.3.3.171. PMid:12271162.
52. Preul C, Kuhn B, Lang EW, et al. Differentiation of cerebral tumors using multi-section echo planar MR perfusion imaging. Eur J Radiol 2003; 48: 244-251. doi:10.1016/S0720-048X(03)00050-0. PMid:14652141.
53. Bertossi M, Virgintino D, Maiorano E, et al. Ultrastructural and morphometric investigation of human brain capillaries in normal and peritumoral tissues. Ultrastruct Pathol 1997; 21: 41-49. doi:10.3109/01913129709023246. PMid:9029765.
54. Hossman KA, Bloink M. Blood flow and regulation of blood flow in experimental peritumoral edema. Stroke 1981; 12: 211-217. doi:10.1161/01.STR.12. 2.211. PMid:7233466.
55. Burger PC, Vogel FS, Green SB, et al. Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implications. Cancer 1985; 56: 1106-1111. doi:10.1002/1097-0142(19850901)56:5〈1106::AID- CNCR2820560525〉3.0.CO;2-2. PMid:2990664.
56. Bulakbasi N, Kocaoglu M, Farzaliyev A, et al. Assessment of diagnostic accuracy of perfusion MR imaging in primary and metastatic solitary malignant brain tumors. AJNR Am J Neuroradiol 2005; 26: 2187-2199. PMid:16219821.
57. Calli C, Kitis O, Yunten N, et al. Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors. Eur J Radiol 2006; 58: 394-403. doi:10.1016/j.ejrad.2005.12.032. PMid:16527438.
58. Lehmann P, Saliou G, de Marco G, et al. Cerebral peritumoral oedema study: does a single dynamic MR sequence assessing perfusion and permeability can help to differentiate glioblastoma from metastasis? Eur J Radiol 2012; 81: 522-527. doi:10.1016/j.ejrad.2011.01.076. PMid:21334839.